Country for PR: United States
Contributor: PR Newswire New York
Monday, July 08 2019 - 15:03
AsiaNet
iMedX, Inc. Launches Industry Leading Analytics and Business Intelligence with Acquisition of Prevalent, Inc. and Axcension, Inc.
ATLANTA and KATY, Texas, July 8, 2019 /PRNewswire-AsiaNet/--

-- Combined Technology & Teams Will Provide Healthcare Clients Unparalleled 
   Insight into Operations and Billing Functions

-- Existing iMedX Solutions Will Utilize Precision Analytics to Further 
   Increase Efficiency and Boost Cash Flow

iMedX, Inc. (iMedX), an international leader in revenue cycle management, 
medical documentation, and health information solutions has successfully 
completed the acquisition of Prevalent, Inc. (Prevalent) and Axcension, Inc. 
(Axcension). Both Axcension and Prevalent are proven providers of cutting-edge 
healthcare analytics and revenue cycle management consulting services.

Logo - https://mma.prnewswire.com/media/259438/imedx_logo.jpg 

The acquisition of these organizations completes another phase of iMedX's 
ongoing global strategy to enhance healthcare technology and enable unparcelled 
insight into operations for healthcare facilities with the ultimate goal of 
improving patient care while also reducing costs. 

Proprietary analytics technology from Prevalent, Axcension, and iMedX has been 
combined to create a never before seen business intelligence solution for 
healthcare providers, which allows for complete transparency and understanding 
across multiple systems.

"A comprehensive analytics platform will be a vital part of every provider's 
RCM workflow in the coming years, which is why these acquisitions are so 
important to us," said Christopher Foley, Chairman and CEO of iMedX. "Having 
thorough insight into billing operations will be a necessity as we continue to 
maximize reimbursement for our clients in an everchanging regulatory 
environment."

New iMedX Analytics will enable healthcare providers to make smarter decisions 
by giving them a streamlined system to explore all of their organization's data 
quickly. Through advanced rules and automated monitoring, billing problems or 
potential areas of improvement can be identified swiftly and resolved. 

Existing iMedX products and services such as medical transcription, medical 
coding, coding education, and consulting projects will also utilize the 
enhanced analytics technology to ensure maximum efficiency and increased ROI 
for customers. 

"These acquisitions bring together the brightest minds and technology to form 
one cohesive team dedicated to helping clients achieve their operational and 
financial goals," said Foley. "Our capabilities are more sweeping than ever 
before, and we can now reach a much broader set of healthcare clients and 
moreover achieve our goal of reducing costs and improving patient care across 
the United States."

ABOUT IMEDX 

Founded in 2002, iMedX is an integrated medical document management and health 
information solutions company based in Atlanta, GA. Through its continuously 
growing technological capabilities, iMedX offers a full suite of high-value 
revenue cycle management solutions, including medical transcription, medical 
coding services, results-based consulting, education opportunities, and data 
analytics. For more information, visit iMedX online at imedx.com.

ABOUT PREVALENT

Prevalent enables healthcare providers to achieve financial excellence through 
data analytics, custom technology solutions, and revenue cycle management and 
recovery services.

Prevalent's robust technology features system automation that intelligently 
prioritizes accounts receivable activities optimize workflows and deliver 
actionable financial insights through elegant dashboards.

ABOUT AXCENSION

Axcension has proven track record of providing leading-edge analytics and 
developing customized technology solutions through working with Allstate, 
Unicef, the United Nations, and leading healthcare providers across the United 
States.

Media Contact
Bradford Foley
bfoley@imedx.com
+1-404-418-0096 ext. 1278

SOURCE: iMedX, Inc.
Translations

Hindi